168 related articles for article (PubMed ID: 24521741)
1. Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.
Liu AY; Liu DG; Du YJ; Pei FH; Yang G; Liu BR; Zhang HT; Wang XH; Fan YJ; Chen YZ; Jiang Y; Chen J
Cancer Biol Ther; 2014 May; 15(5):489-95. PubMed ID: 24521741
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.
Cui G; Qi H; Gundersen MD; Yang H; Christiansen I; Sørbye SW; Goll R; Florholmen J
Cancer Immunol Immunother; 2015 Feb; 64(2):181-90. PubMed ID: 25324197
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the nitrogen permease regulator-like-2 candidate tumor suppressor gene in colorectal cancer cell lines.
Liu AY; Liu MN; Pei FH; Chen J; Wang XH; Liu D; Du YJ; Liu BR
Mol Med Rep; 2015 Sep; 12(3):3487-3493. PubMed ID: 26044952
[TBL] [Abstract][Full Text] [Related]
4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.
Tang Y; Jiang L; Tang W
Pathol Oncol Res; 2014 Oct; 20(4):829-37. PubMed ID: 24789683
[TBL] [Abstract][Full Text] [Related]
6. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
[TBL] [Abstract][Full Text] [Related]
7. Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.
Hosono K; Yamada E; Endo H; Takahashi H; Inamori M; Hippo Y; Nakagama H; Nakajima A
World J Gastroenterol; 2012 Oct; 18(38):5360-8. PubMed ID: 23082052
[TBL] [Abstract][Full Text] [Related]
8. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
[TBL] [Abstract][Full Text] [Related]
9. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
10. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
11. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
12. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
13. NPRL2 gene expression in the progression of colon tumors.
Yogurtcu B; Hatemi I; Aydin I; Buyru N
Genet Mol Res; 2012 Sep; 11(4):4810-6. PubMed ID: 23079973
[TBL] [Abstract][Full Text] [Related]
14. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
17. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Florholmen J
Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of mucin-associated sialyl-Tn antigen in Chinese patients with different colorectal lesions (adenomas, carcinomas).
Xu F; Fan C; Fan S; Liu F; Wen T; An G; Feng G
Int J Clin Exp Pathol; 2015; 8(9):11549-54. PubMed ID: 26617889
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive look at transcription factor gene expression changes in colorectal adenomas.
Vonlanthen J; Okoniewski MJ; Menigatti M; Cattaneo E; Pellegrini-Ochsner D; Haider R; Jiricny J; Staiano T; Buffoli F; Marra G
BMC Cancer; 2014 Jan; 14():46. PubMed ID: 24472434
[TBL] [Abstract][Full Text] [Related]
20. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
